by Cort Johnson | Sep 13, 2018 | Autoimmune, Fibromyalgia, Homepage, IVIG, Klimas, Levine, POTS, Treatment
“The bottom line is that we should rethink this whole area and encourage proper clinical trials.” Dr. Nancy Klimas This article is the last of a three-part series on IVIG which came out of my attending the 2018 Dysautonomia Conference in Nashville, Tennessee. An IVIG... 
by Cort Johnson | Aug 17, 2018 | Clonidine, Conference Reports, Homepage, Ivabradine, Mast cell activation syndrome, POTS, Propanolol
Italo Biaggioni, a respected Vanderbilt researcher in the field, has co-authored 100’s of studies on dysautonomia. He was an impressive speaker, at ease and relaxed in front of the room. I felt like I was sitting in his living room. He noted that the... 
by Cort Johnson | Aug 15, 2018 | Antiphospholipid Antibody Syndrome, Antiphospholipid Antibody Syndrome, Autoimmune, Autonomic Nervous System, Conference Reports, Heparin, Homepage, POTS
This blog is part IV in a series of blogs covering the issues presented at the 2018 Dysautonomia International Conference in Nashville, Tennessee. As if we needed another syndrome. Chronic fatigue syndrome (ME/CFS), postural orthostatic tachycardia syndrome (POTS),... 
by Cort Johnson | Aug 13, 2018 | Autoimmune, Autonomic Nervous System, Conference Reports, Homepage, Immune, IVIG, POTS
Thinking Outside the Box This is the second of three posts on IVIG treatment and autoimmunity in chronic fatigue syndrome (ME/CFS), POTS and fibromyalgia. It’s time to start thinking outside the traditional ME/CFS/POTS/FM boxes. It’s possible that if you’ve... 
by Cort Johnson | Aug 11, 2018 | Autoimmune, Homepage, IVIG, POTS
Suzi’s story is the first in a series of blogs exploring the possibility that the autoimmune findings will open the door for IVIG (Intravenous Immunoglobulin) treatment in chronic fatigue syndrome (ME/CFS), fibromaylgia (FM) and postural orthostatic tachycardia... 
by Cort Johnson | Jul 14, 2018 | Cortene, Homepage, Treatment
Since February, Health Rising has described the development of a new drug produced for chronic fatigue syndrome (ME/CFS) by a small pharmaceutical company named Cortene in three blogs: The Cortene Way: New Drug to Be Trialed in Chronic Fatigue Syndrome (ME/CFS) Soon –...
